Clinical Trial Update: A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures [Phase 3]

View source ↗

Summary

A double-blind, confirmatory Phase 3 trial of levetiracetam in patients with partial-onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED